Pink SheetEli Lilly and Italfarmaco were due this week to appear before the European Medicines Agency’s human medicines committee, the CHMP, for oral explanations as to why their respective drugs, donanemab and
Generics BulletinGlenmark Pharmaceuticals Limited ’s revenue mix by region appears set for an overhaul, with Europe expected to match the US, a market where the Indian firm has been struggling to regain momentum. At t
ScripGlenmark Pharmaceuticals Limited ’s revenue mix by region appears set for an overhaul, with Europe expected to match the US, a market where the Indian firm has been struggling to regain momentum. At t
ScripWho: Grünenthal/Valinor Pharma What: Grünenthal is buying privately held US biotech Valinor on the strength of its lone commercial product, Movantik. Why: Grünenthal is acquiring Valinor to gain